Related Experiment Video
Updated: Apr 13, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Cushing's disease: towards precision medicine.
1Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA.
Somatic mutations in USP8 are linked to Cushing's disease, offering new insights into pituitary tumor development. This discovery paves the way for targeted therapies, potentially revolutionizing treatment through precision medicine.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Cushing's disease pathogenesis remains largely unknown.
- Recent research has identified somatic mutations in USP8 within pituitary corticotroph tumors.
Purpose of the Study:
- To explore the implications of USP8 mutations in Cushing's disease.
- To investigate the potential of targeting EGFR signaling for therapeutic interventions.
Main Methods:
- Analysis of somatic mutations in USP8.
- Investigation of epidermal growth factor receptor (EGFR) trafficking and signaling pathways.
Main Results:
- Somatic mutations in USP8 were identified in pituitary corticotroph tumors.
- These mutations were found to affect EGFR trafficking and signaling.
Conclusions:
- USP8 mutations represent a significant advance in understanding Cushing's disease.
- Targeting EGFR may offer a precision medicine approach for treating Cushing's disease.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Targeted Cancer Therapies
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

